Advanced Approaches in the Treatment of Autoimmune Thrombocytopenic Purpura: A Comparative Analysis of Conservative and Surgical Methods

Authors

  • Kamola X. Abdullayeva Andijan State Medical Institute Assistant of the Department of Outpatient and Polyclinic Therapy Author
  • Zuxriddin. S. Saloxiddinov Andijan State Medical Institute Dc of the Department of Outpatient and Polyclinic Therapy Author

Keywords:

Autoimmune thrombocytopenic purpura, Immune thrombocytopenia, Glucocorticosteroids, Nebulizer therapy, Splenectomy, Hematology, Microvascular hemostasis.

Abstract

Autoimmune thrombocytopenic purpura (ATP), alternatively designated as primary immune thrombocytopenia (ITP) or Werlhof's disease, is an immune-mediated hematological disorder characterized by accelerated antibody-coated platelet destruction and severely impaired megakaryocyte maturation. While conventional therapeutic strategies heavily rely on systemic oral/parenteral glucocorticosteroids and standard open splenectomy, both arms carry high risks of severe treatment-induced mo

References

1.Liu XG, Hou Y, Hou M. How we treat primary immune thrombocytopenia in adults. J Hematol Oncol. 2023;16(1):4. doi:10.1186/s13045-023-01401-z.

2.González-López TJ, Newland A, Provan D. Current concepts in the diagnosis and management of adult primary immune thrombocytopenia. Medicina (Kaunas). 2023;59(4):815. doi:10.3390/medicina59040815.

3.Pulanić D, Bátorová A, Bodó I, et al. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Ann Hematol. 2023;102:715–727.

4.Yassin MA, Al-Rasheed M, Al-Khaboori M, et al. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review. Front Cardiovasc Med. 2023;10:1260487.

5.Torelli DFHB, Oliveira CBS, Nai GA, Trindade EM, Prestes-Carneiro LE. Eltrombopag for adults and children with immune-refractory thrombocytopenic purpura: a systematic review. J Clin Med. 2023;12(12):3872.

6.Godeau B. Is splenectomy a good strategy for refractory immune thrombocytopenia in adults? Br J Haematol. 2023;203(1):86–95.

7.Bashyal KP, Shah S, Ghimire C, et al. Primary immune thrombocytopenic purpura and ITP associated with systemic lupus erythematosus: a review of clinical characteristics and treatment modalities. Case Rep Hematol. 2024;2024:6650921.

8.Kuter DJ. Immune thrombocytopenia (ITP). Merck Manual Professional Edition. Updated 2024.

9.Xu J, Wang Y, Li H, et al. Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: a systematic review and network meta-analysis. eClinicalMedicine. 2023;56:101777.

10.Canadian Agency for Drugs and Technologies in Health (CADTH). Treatment of adult patients with chronic immune thrombocytopenia after failure of first-line therapies. Ottawa; 2023.

11.Kessler CM, Nagalla S. Immune thrombocytopenia (ITP) guidelines. Medscape. 2025.

12.Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2022;386(10):945–955.

13.Rodeghiero F, Michel M. Advances in immune thrombocytopenia pathogenesis and therapy. Haematologica. 2022;107(11):2521–2532.

14.Provan D, Arnold DM, Bussel JB. Updated international perspectives on immune thrombocytopenia management. Blood Rev. 2022;56:100982.

15.Mahévas M, Gerfaud-Valentin M, Moulis G. Long-term outcomes of splenectomy in adult immune thrombocytopenia. Blood Adv. 2021;5(18):3574–3582.

16.Neunert C, Terrell DR, Arnold DM, et al. Contemporary management of immune thrombocytopenia: emerging therapies and clinical challenges. Hematology Am Soc Hematol Educ Program. 2024;1:312–321.

17.Miah H, Kollias D, Pedone GL, Provan D, Chen F. Can machine learning assist in diagnosis of primary immune thrombocytopenia? A feasibility study. Front Digit Health. 2024.

Downloads

Published

2026-11-10